TY - JOUR
T1 - Genetic Classification of Gliomas
T2 - Refining Histopathology
AU - Foote, Michael B.
AU - Papadopoulos, Nickolas
AU - Diaz, Luis A.
N1 - Publisher Copyright:
© 2015 Elsevier Inc..
PY - 2015/7/13
Y1 - 2015/7/13
N2 - Newly published studies validate prior reports that specific combinations of genetic alternations in IDH1/2, ATRX, TERT, TP53, and co-deletion of 1p/19q have the ability to reclassify gliomas into rational subsets, defining a glioma's biological and clinical behavior more accurately than stratifications based solely on histopathology. Newly published studies validate prior reports that specific combinations of genetic alternations in IDH1/2, ATRX, TERT, TP53, and co-deletion of 1p/19q have the ability to reclassify gliomas into rational subsets, defining a glioma's biological and clinical behavior more accurately than stratifications based solely on histopathology.
AB - Newly published studies validate prior reports that specific combinations of genetic alternations in IDH1/2, ATRX, TERT, TP53, and co-deletion of 1p/19q have the ability to reclassify gliomas into rational subsets, defining a glioma's biological and clinical behavior more accurately than stratifications based solely on histopathology. Newly published studies validate prior reports that specific combinations of genetic alternations in IDH1/2, ATRX, TERT, TP53, and co-deletion of 1p/19q have the ability to reclassify gliomas into rational subsets, defining a glioma's biological and clinical behavior more accurately than stratifications based solely on histopathology.
UR - http://www.scopus.com/inward/record.url?scp=84937485443&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84937485443&partnerID=8YFLogxK
U2 - 10.1016/j.ccell.2015.06.014
DO - 10.1016/j.ccell.2015.06.014
M3 - Short survey
C2 - 26175411
AN - SCOPUS:84937485443
SN - 1535-6108
VL - 28
SP - 9
EP - 11
JO - Cancer cell
JF - Cancer cell
IS - 1
ER -